Accelovance

This is the limited version of the Accelovance company profile: Join LinkedIn or Sign In to see more information.

Accelovance, Inc., a clinical research organization, provides clinical trial, patient recruitment, and market commercialization services in the United States and China. It offers clinical sites, project management, clinical monitoring, data management, quality assurance, and medical monitoring services. The company also provides quality control/study coordination and data management/biostatistics, as well as business formation, import drug registration, manufacturing/packaging, marketing and sales, and distribution services. It serves pharmaceutical and biotech clients. Accelovance, Inc. was founded in 2004 and is headquartered in Rockville, Maryland.

CapitalIQ | More Accelovance research »

Your Connections to Accelovance

To see how you’re connected: Join Now or Sign In

Popular Profiles at Accelovance

New Hires and Recent Promotions at Accelovance

  • Garrett Smith, Vice President, Business Development/Marketing

    was Assoc Vice President - 6 months ago

To see more new hires & promotions: Join Now or Sign In

Key Statistics about Accelovance

Top Locations

Accelovance Headquarters Address
2275 Research Boulevard Suite 700
Rockville, MD 20850
United States
Phone: 240-238-4900
Fax: 240-238-4901
HeadquartersWashington D.C. Metro Area
IndustryBiotechnology
TypePrivately Held
StatusOperating
Company Size 51-200 employees
Founded2004
Websitehttp://www.accelovance.co...
More Accelovance info »
Median Age33 years
Gender
Male37%
Female63%
Estimated based on LinkedIn Data

In partnership with BusinessWeek

Send feedback on BusinessWeek/CapIQ content to linkedinissues@capitaliq.com. Copyright © 2009 Capital IQ.

This LinkedIn Company Profile was created by LinkedIn and is about Accelovance. This page is not endorsed by or affiliated with Accelovance. For questions regarding LinkedIn Company Profiles, contact us.

Accelovance full company profile, top executives, board of directors & more.